P27(Kip1)is Overexpressed in Very Early Stages of Hepatocarcinogenesis

Overview

Journal Cancer Sci

Specialty Oncology

Date 2008 Sep 24

PMID 18808421

Citations 3

Authors

Shinichi Yachida

Michiie Sakamoto

Katsumi Imaida

Masanao Yokohira

Kousuke Saoo

Keiichi Okano

Hisao Wakabayashi

Hajime Maeta

Yasuyuki Suzuki

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) associated with chronic liver disease evolves from precancerous lesions and early HCC to more malignant forms. Despite the demonstrated importance of cell-cycle regulators in tumor biology, there have been few studies of their role in multistep hepatocarcinogenesis. Expression of p27(Kip1) and a degradation pathway associated protein, S-phase kinase-interacting protein 2 (Skp2), was therefore evaluated in surgically resected specimens of eight adenomatous hyperplasias, 16 early HCC and 126 classical HCC. Immunohistochemistry revealed no p27(Kip1) expression in the majority of hepatocytes from normal and cirrhotic liver, whereas positive staining for p27(Kip1) protein was found in 75.0% and 93.8% of adenomatous hyperplasias and early HCC, respectively. The average p27(Kip1) labeling indices (LI) for adenomatous hyperplasias, early HCC, well differentiated HCC, moderately differentiated HCC and poorly differentiated HCC were 36.99, 43.59, 47.73, 49.24, and 30.21, respectively. Real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) analyses confirmed the increases. Skp2 LI were also significantly elevated in accordance with stepwise progression of hepatocarcinogenesis. Increased expression of Skp2 mRNA was observed most frequently in less differentiated tumors and Kaplan-Meier survival analysis showed a significantly association with a poor prognosis (P = 0.0496). In conclusion, a high level of p27(Kip1) expression is evident from early stages of hepatocarcinogenesis, indicating that this parameter could be a useful diagnostic marker for precancerous lesions and early HCC. In addition, Skp2 expression correlates with tumor dedifferentiation and may contribute to biological aggression in HCC.

Citing Articles

Heat shock protein 70 downregulation inhibits proliferation, migration and tumorigenicity in hepatocellular carcinoma cells.

Xiong J, Jiang X, Mao S, Yu X, Huang X Oncol Lett. 2017; 14(3):2703-2708.

PMID: 28928813 PMC: 5588163. DOI: 10.3892/ol.2017.6531.

p27 Is a critical prognostic biomarker in non-alcoholic steatohepatitis-related hepatocellular carcinoma.

Matsuda Y, Wakai T, Hirose Y, Osawa M, Fujimaki S, Kubota M Int J Mol Sci. 2013; 14(12):23499-515.

PMID: 24351862 PMC: 3876059. DOI: 10.3390/ijms141223499.

Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model.

Liu Y, Zha B, Zhang H, Zhu X, Li Y, Zhu J J Exp Clin Cancer Res. 2009; 28:107.

PMID: 19638242 PMC: 2729293. DOI: 10.1186/1756-9966-28-107.

References

Morimitsu Y, Hsia C, Kojiro M, Tabor E . Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma: relative expression of transforming growth factor-alpha and its receptor in the different areas of tumor. Hum Pathol. 1995; 26(10):1126-32. DOI: 10.1016/0046-8177(95)90275-9. View

Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T . Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Hepatology. 1999; 30(1):90-9. DOI: 10.1002/hep.510300114. View

Fiorentino M, Altimari A, DErrico A, Cukor B, Barozzi C, Loda M . Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma. Clin Cancer Res. 2000; 6(10):3966-72. View

Sakamoto M . Pathology of early hepatocellular carcinoma. Hepatol Res. 2007; 37 Suppl 2:S135-8. DOI: 10.1111/j.1872-034X.2007.00176.x. View

Hershko D, Bornstein G, Ben-Izhak O, Carrano A, Pagano M, Krausz M . Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer. 2001; 91(9):1745-51. DOI: 10.1002/1097-0142(20010501)91:9<1745::aid-cncr1193>3.0.co;2-h. View

Hara T, Kamura T, Oshikawa K, Hatakeyama S, Nakayama K . Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway. J Biol Chem. 2001; 276(52):48937-43. DOI: 10.1074/jbc.M107274200. View

Kotoshiba S, Kamura T, Hara T, Ishida N, Nakayama K . Molecular dissection of the interaction between p27 and Kip1 ubiquitylation-promoting complex, the ubiquitin ligase that regulates proteolysis of p27 in G1 phase. J Biol Chem. 2005; 280(18):17694-700. DOI: 10.1074/jbc.M500866200. View

Sakamoto M, Hirohashi S . Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multi-institutional analysis of 53 nodules followed up for more than 6 months and 141 patients with single early hepatocellular carcinoma treated by.... Jpn J Clin Oncol. 1998; 28(10):604-8. DOI: 10.1093/jjco/28.10.604. View

Carrano A, Eytan E, Hershko A, Pagano M . SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1999; 1(4):193-9. DOI: 10.1038/12013. View

10.

Nagahama H, Minamishima Y, Matsumoto M, Nakamichi I, Kitagawa K, Shirane M . Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J. 2000; 19(9):2069-81. PMC: 305685. DOI: 10.1093/emboj/19.9.2069. View

11.

Sakamoto M, Hirohashi S, Shimosato Y . Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol. 1991; 22(2):172-8. DOI: 10.1016/0046-8177(91)90039-r. View

12.

Masuda T, Inoue H, Sonoda H, Mine S, Yoshikawa Y, Nakayama K . Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res. 2002; 62(13):3819-25. View

13.

Drobnjak M, Melamed J, Taneja S, Melzer K, Wieczorek R, Levinson B . Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients. Clin Cancer Res. 2003; 9(7):2613-9. View

14.

Lee M, Reynisdottir I, Massague J . Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 1995; 9(6):639-49. DOI: 10.1101/gad.9.6.639. View

15.

Armengol C, Boix L, Bachs O, Sole M, Fuster J, Sala M . p27(Kip1) is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma. J Hepatol. 2003; 38(5):591-7. DOI: 10.1016/s0168-8278(03)00025-4. View

16.

Oikawa T, Ojima H, Yamasaki S, Takayama T, Hirohashi S, Sakamoto M . Multistep and multicentric development of hepatocellular carcinoma: histological analysis of 980 resected nodules. J Hepatol. 2005; 42(2):225-9. DOI: 10.1016/j.jhep.2004.10.024. View

17.

Radke S, Pirkmaier A, Germain D . Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer. Oncogene. 2005; 24(21):3448-58. DOI: 10.1038/sj.onc.1208328. View

18.

Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J . Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci U S A. 2001; 98(9):5043-8. PMC: 33160. DOI: 10.1073/pnas.081474898. View

19.

Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda T, Mori M . Significance of skp2 expression in primary breast cancer. Clin Cancer Res. 2006; 12(4):1215-20. DOI: 10.1158/1078-0432.CCR-05-1709. View

20.

Hui A, Sun L, Kanai Y, Sakamoto M, Hirohashi S . Reduced p27Kip1 expression in hepatocellular carcinomas. Cancer Lett. 1999; 132(1-2):67-73. DOI: 10.1016/s0304-3835(98)00164-5. View